# Sri Krishna Pharmaceuticals Limited - Inspection Records

Source: https://www.globalkeysolutions.net/companies/sri-krishna-pharmaceuticals-limited/5afbb0e4-2595-4bfc-8ecd-7c0d9deb8b38

> Inspection records and compliance data for Sri Krishna Pharmaceuticals Limited in Hyderabad, None. Access full analysis and detailed observations.

---

## Details

- Name: Sri Krishna Pharmaceuticals Limited
- FEI Number: 3005280525
- City: Hyderabad
- State: None
- Country Name: India
- Address Line 1: Unit II, Plots A-34, A-35, Ida Nacharam, Uppal Mandal, Medchal-Malkajgiri District
- Zip Code: None
- Business Operations: API MANUFACTURE, FDF MANUFACTURE

## Related Documents

- [483 - Sri Krishna Pharmaceuticals Limited - 2025-06-27](https://www.globalkeysolutions.net/records/483/sri-krishna-pharmaceuticals-limited/35c8f8b8-c6d7-42db-bc15-1103a9b10ebc) — source: FDA, date: June 27, 2025
- [FDA Inspection 1273929 - Sri Krishna Pharmaceuticals Limited - 2025-06-27](https://www.globalkeysolutions.net/records/fda_inspections/sri-krishna-pharmaceuticals-limited/21b8f5a8-a1ed-47d8-8a0e-11f8d6d39727) — classification: Official Action Indicated (OAI), source: FDA, date: June 27, 2025
- [483 - Sri Krishna Pharmaceuticals Limited - 2023-05-19](https://www.globalkeysolutions.net/records/483/sri-krishna-pharmaceuticals-limited/69fbf128-0b1e-444d-9894-808870210337) — source: FDA, date: May 19, 2023
- [FDA Inspection 1206168 - Sri Krishna Pharmaceuticals Limited - 2023-05-19](https://www.globalkeysolutions.net/records/fda_inspections/sri-krishna-pharmaceuticals-limited/c00c65b4-1cec-4f8b-9bdf-35d0fbd1b46a) — classification: Official Action Indicated (OAI), source: FDA, date: May 19, 2023
- [FDA Inspection 913677 - Sri Krishna Pharmaceuticals Limited - 2014-12-04](https://www.globalkeysolutions.net/records/fda_inspections/sri-krishna-pharmaceuticals-limited/ad2e850f-effc-4c88-8e41-c99e8c91ae15) — classification: Official Action Indicated (OAI), source: FDA, date: December 4, 2014
- [FDA Inspection 757337 - Sri Krishna Pharmaceuticals Limited - 2011-11-23](https://www.globalkeysolutions.net/records/fda_inspections/sri-krishna-pharmaceuticals-limited/9612ef6c-76a3-4868-af5a-75859c0256b8) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 23, 2011

## Related Companies

- [BASF SE](https://www.globalkeysolutions.net/companies/basf-se/96b65069-a37b-4a26-9655-5f310b60cc6f)
- [Kumar Organic Products Ltd.](https://www.globalkeysolutions.net/companies/kumar-organic-products-ltd/acc61a81-a684-4eb3-a4c8-d487dc0164e5)
- [Dasami Lab Private Limited](https://www.globalkeysolutions.net/companies/dasami-lab-private-limited/950d9812-d647-4e9e-ad9a-01eab0ebe091)
- [Fresenius Kabi Oncology Ltd](https://www.globalkeysolutions.net/companies/fresenius-kabi-oncology-ltd/c145255a-d691-4f05-8873-bf1e09b6aa97)
- [Changzhou Sunlight Pharmaceutical Co., Ltd.](https://www.globalkeysolutions.net/companies/changzhou-sunlight-pharmaceutical-co-ltd/8dec389f-df74-4d58-8aa0-61eba8abd2eb)
- [Asahi Kasei Finechem Co., Ltd.](https://www.globalkeysolutions.net/companies/asahi-kasei-finechem-co-ltd/a6e157c7-1e20-4cf3-85d1-d9f64c58a6c0)
- [Valens Molecules Private Limited](https://www.globalkeysolutions.net/companies/valens-molecules-private-limited/782b14d8-72b3-4782-9a8c-fdf4373bee0b)
- [PharmaZell GmbH](https://www.globalkeysolutions.net/companies/pharmazell-gmbh/37149959-807d-41b5-be90-cc07ca5a6098)
- [Sichuan Qingmu Pharmaceutical Co., Ltd](https://www.globalkeysolutions.net/companies/sichuan-qingmu-pharmaceutical-co-ltd/821a1489-2969-47a3-8321-b97728ac795a)
- [Minteq UK Limited](https://www.globalkeysolutions.net/companies/minteq-uk-limited/08f82870-b388-4939-8b90-729be4cd9154)

## Related Officers

- [Arsen Karapetyan](https://www.globalkeysolutions.net/people/arsen-karapetyan/4000d909-277b-4533-992f-4e3627c8ce40)
- [Research Specialist II](https://www.globalkeysolutions.net/people/justin-a-boyd/796c9c9d-02db-486c-bdca-cc259066a0e2)
- [Wayne D. Mcgrath](https://www.globalkeysolutions.net/people/wayne-d-mcgrath/42db5ab0-2e0b-4909-951c-e7621cd04f6e)